Infosys shares swing after acquisition plans, brokerages positive; Nifty IT index resilient

Shares of rose in early trade on Friday after the company announced plans to acquire healthcare digital transformation firm Optimum Healthcare IT and insurance technology consulting company Stratus Global in deals worth about $560 million.

The stock rose around 1 per cent in early trade, moving within a range of ₹1,273.60 to ₹1,294.80 on the NSE, before turning flat at ₹1,276.70 at 11.16 am, compared with its previous close of ₹1,279.10.

KEY HIGHLIGHTS
Infosys rose 1% on $560 million acquisition plan
Stock turns flat after early gains
Nifty IT Index stays resilient; select IT stocks in green
Emkay Global Financial Services and JM Financial retain buy calls on Infosys; see growth boost

However, the Nifty IT Index remained resilient despite the broader market downturn in today’s session, with stocks such as Oracle Financial Services Software, Tata Consultancy Services, Wipro and Persistent Systems continuing to trade in positive territory.

Brokerage Emkay Global Financial Services said the acquisitions would strengthen Infosys’ vertical capabilities in healthcare and insurance, while deepening integration of its AI platform Topaz and cloud offering Cobalt. The brokerage noted that the deals would enhance the company’s positioning in regulated and high-complexity sectors. Emkay retained its buy rating on the stock with a target price of ₹1,450, adding that the acquisitions could contribute around 1.6 per cent to revenue run rate.

According to Emkay, the Optimum Healthcare IT acquisition would significantly expand Infosys’ footprint in the healthcare provider segment by adding new clients and capabilities, while enabling cross-selling of its broader digital and AI-led services. The Stratus deal, it said, would bolster Infosys’ presence in the property and casualty insurance segment through stronger platform consulting and modernization capabilities.



Brokerage JM Financial also maintained a buy rating, highlighting that the acquisitions align with Infosys’ strategy of capability-led expansion. The firm estimated that Optimum could add about 1.4 per cent to Infosys’ revenue annually post closure, while Stratus may contribute an additional 0.2 per cent.

JM Financial added that the deals would enhance Infosys’ domain expertise in healthcare IT and insurance technology, while enabling clients to leverage its AI, cloud, and data-driven transformation offerings. It also pointed out that mergers and acquisitions remain a key strategic priority for Indian IT firms as they look to strengthen portfolios in a challenging macro environment.

Despite the positive strategic rationale, the stock remained range-bound as investors assessed execution timelines and awaited regulatory approvals, with both transactions expected to close by the first quarter of FY27.

More Like This

Source

Leave a Reply

Your email address will not be published. Required fields are marked *

one + 9 =